Mersana Therapeutics, Inc. (MRSN) Bundle
Mersana Therapeutics Reports -275.91% ROIC in Peer Analysis
Mersana Therapeutics, Inc. (NASDAQ:MRSN) recorded a Return on Invested Capital (ROIC) of -275.91% as of December 22, 2025. This efficiency metric remains significantly lower than the company's Weighted Average Cost of Capital (WACC) of 7.09%, resulting in a ROIC to WACC ratio of -38.90.
The clinical-stage biopharmaceutical company, which specializes in antibody-drug conjugates (ADCs), shows the lowest capital efficiency among its primary industry peers. The analysis indicates that Mersana Therapeutics is currently unable to generate returns that exceed its cost of capital, a challenge shared by several competitors in the oncology sector.
Comparative data for industry peers highlights varying levels of capital management efficiency:
- MacroGenics: Reported a ROIC of -49.77% and a WACC of 8.83%, achieving a ROIC to WACC ratio of -5.64.
- Kura Oncology: Recorded a ROIC of -45.39% and a WACC of 4.79%, resulting in a ratio of -9.48.
- Deciphera Pharmaceuticals: Posted a ROIC of -56.11% with a ROIC to WACC ratio of -10.89.
- Syndax Pharmaceuticals: Reported a ROIC of -66.59% and a ratio of -11.94.
- Scholar Rock Holding Corporation: Recorded a ROIC of -101.98% and a WACC of 6.68%, leading to a ratio of -15.26.
Despite these financial metrics, Mersana Therapeutics continues its focus on developing innovative cancer treatments. Further information regarding the company's development can be found in the MRSN-history-mission-ownership and the MRSN-mission-vision. Additional details on financial performance and investor relations are available at MRSN-financial-health and the MRSN-investor-profile.
Mersana Therapeutics, Inc. (MRSN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.